Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
growth source : Www.biospace.com save search
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Published: 2024-04-19 (Crawled : 21:00) - biospace.com/
NOVT | News | $149.28 -0.49% -0.5% 160K
|
Electronic Technology
|
| O: -3.53%
H: 1.09%
C: 0.25%
conference growth
Stemtech Corporation on Track for CEO and Chairman's Goal for Growth and Global Expansion
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
STEK | News | $0.063 -62.89% 180K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -14.29%
ceo corporation expansion global for growth
Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
ENSC | News | $0.561 -3.31% -3.42% 190K
|
Health Technology
|
| O: -5.53%
H: 0.0%
C: -6.56%
conference presentation growth
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Published: 2024-04-10 (Crawled : 13:00) - biospace.com/
IINN | $1.83 1.11% 1.1% 91K
|
Manufacturing
|
| O: 2.06%
H: 19.19%
C: 5.05%
bloodstream infections results show growth study
Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
SYRA | $1.07 0.93% 0.93% 120K
|
n/a
|
| O: -2.33%
H: 0.6%
C: -10.71%
health revenue financial growth
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Published: 2024-03-19 (Crawled : 12:00) - biospace.com/
SSKN | $0.56 5.15% 4.89% 75K
|
Health Technology
|
| O: 1.28%
H: 9.63%
C: -2.2%
avoid family growth
Parexel Announces CEO Succession PlanChief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024
Published: 2024-03-18 (Crawled : 15:00) - biospace.com/
TNDM | $30.445 -1.57% -1.59% 990K
|
Health Technology
|
| O: 0.7%
H: 8.21%
C: 7.98%
ceo growth
UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102
Published: 2024-03-14 (Crawled : 13:00) - biospace.com/
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: -4.01%
H: 0.69%
C: -14.55%
ugn-102 jelmyto pharma company growth submission
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
RGBP | $0.7 5.69% 11K
|
Manufacturing
|
| O: 1.51%
H: 11.2%
C: 7.5%
conference growth
Dermata to Present at the Emerging Growth Conference on February 7, 2024
Published: 2024-02-01 (Crawled : 20:00) - biospace.com/
DRMA | $0.321 -5.09% -5.36% 28K
|
|
| O: -3.67%
H: 0.0%
C: -3.11%
conference growth
Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products
Published: 2024-02-01 (Crawled : 09:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: -1.98%
fy2023 management momentum growth
Niterra Leads $10M Growth Funding Round for Imbed Biosciences
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
NGKSF | $21.61 0% 100
|
n/a
| Email alert
Add to watchlist
NGKSY | $15.64 -35.1% 220
|
n/a
| Email alert
Add to watchlist
funding growth
Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.55%
H: 1.45%
C: 1.42%
conference business growth
Zynex to Participate at the Needham Annual Growth Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
ZYXI | $11.365 -0.74% -0.75% 180K
|
Health Technology
|
| O: 0.65%
H: 4.24%
C: 2.21%
conference growth
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
Published: 2023-12-19 (Crawled : 15:30) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.66%
H: 17.46%
C: 13.07%
ceo innovation growth
J&J Expects Up to 6% Growth Next Year with 20-Plus New Drugs by 2030
Published: 2023-12-05 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
year growth
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
Published: 2023-12-05 (Crawled : 14:30) - biospace.com/
RGBP | $0.7 5.69% 11K
|
Manufacturing
|
| O: -3.39%
H: 4.39%
C: 1.75%
conference growth
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
Published: 2023-12-05 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 1.05%
H: 0.46%
C: -1.59%
partnership commercial therapeutics growth
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
Published: 2023-11-30 (Crawled : 16:00) - biospace.com/
AYTU | $2.84 1.79% 1.76% 6.9K
|
Health Technology
|
| O: 1.28%
H: 0.84%
C: -3.78%
conference biopharma growth
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
SHPH | $0.409 1.89% 1.86% 12K
|
|
| O: -0.1%
H: 3.07%
C: 3.05%
conference pharmaceuticals growth
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.